Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2001 1
2003 1
2004 2
2007 1
2008 1
2009 1
2010 2
2011 1
2014 1
2015 4
2016 1
2017 1
2018 1
2019 2
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
Tangri N, Mathur VS, Bushinsky DA, Klaerner G, Li E, Parsell D, Stasiv Y, Walker M, Wesson DE, Wheeler DC, Perkovic V, Inker LA. Tangri N, et al. Among authors: stasiv y. J Am Soc Nephrol. 2024 Mar 1;35(3):311-320. doi: 10.1681/ASN.0000000000000292. Epub 2024 Jan 23. J Am Soc Nephrol. 2024. PMID: 38261535 Clinical Trial.
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Parsell D, Shao J, Guttendorf R, Mathur V, Li E, Wu YS, Tsao L, Tabakman S, Stasiv Y, Lee A, Biyani K, Klaerner G. Parsell D, et al. Among authors: stasiv y. Drug Metab Dispos. 2021 Jul;49(7):490-500. doi: 10.1124/dmd.121.000366. Epub 2021 May 24. Drug Metab Dispos. 2021. PMID: 34031138 Clinical Trial.
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Mathur VS, Bushinsky DA, Inker L, Klaerner G, Li E, Parsell D, Perkovic V, Stasiv Y, Walker M, Wesson DE, Wheeler DC, Tangri N. Mathur VS, et al. Among authors: stasiv y. Nephrol Dial Transplant. 2023 May 31;38(6):1448-1458. doi: 10.1093/ndt/gfac289. Nephrol Dial Transplant. 2023. PMID: 36331426 Clinical Trial.
Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
Bushinsky DA, Hostetter T, Klaerner G, Stasiv Y, Lockey C, McNulty S, Lee A, Parsell D, Mathur V, Li E, Buysse J, Alpern R. Bushinsky DA, et al. Among authors: stasiv y. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):26-35. doi: 10.2215/CJN.07300717. Epub 2017 Nov 4. Clin J Am Soc Nephrol. 2018. PMID: 29102959 Free PMC article. Clinical Trial.
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.
Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators. Weir MR, et al. Among authors: stasiv y. N Engl J Med. 2015 Jan 15;372(3):211-21. doi: 10.1056/NEJMoa1410853. Epub 2014 Nov 21. N Engl J Med. 2015. PMID: 25415805 Free article. Clinical Trial.
Nitric oxide negatively regulates mammalian adult neurogenesis.
Packer MA, Stasiv Y, Benraiss A, Chmielnicki E, Grinberg A, Westphal H, Goldman SA, Enikolopov G. Packer MA, et al. Among authors: stasiv y. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9566-71. doi: 10.1073/pnas.1633579100. Epub 2003 Jul 28. Proc Natl Acad Sci U S A. 2003. PMID: 12886012 Free PMC article.
Essential function of nitric oxide synthase in Drosophila.
Regulski M, Stasiv Y, Tully T, Enikolopov G. Regulski M, et al. Among authors: stasiv y. Curr Biol. 2004 Oct 26;14(20):R881-2. doi: 10.1016/j.cub.2004.09.068. Curr Biol. 2004. PMID: 15498477 Free article. No abstract available.
22 results